Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHC”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01879462
What this trial is testing

A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 47
Not applicableEnded earlyNCT02315638
What this trial is testing

Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Post-approval studies (Phase 4)Study completedNCT01378104
What this trial is testing

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Who this might be right for
Sustained Virologic ResponseIL28B Polymorphism
The Catholic University of Korea 178
Post-approval studies (Phase 4)Study completedNCT00948220
What this trial is testing

Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm 26
Post-approval studies (Phase 4)Study completedNCT02864199
What this trial is testing

Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 63
Post-approval studies (Phase 4)Study completedNCT01258101
What this trial is testing

PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 395
Post-approval studies (Phase 4)UnknownNCT01056172
What this trial is testing

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Who this might be right for
Chronic Hepatitis C
Pusan National University Yangsan Hospital 164
Testing effectiveness (Phase 2)Study completedNCT01710501
What this trial is testing

Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Who this might be right for
Chronic Hepatitis C (CHC)
Merck Sharp & Dohme LLC 87
Not applicableEnded earlyNCT01168856
What this trial is testing

An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 734
Post-approval studies (Phase 4)Study completedNCT03144635
What this trial is testing

G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

Who this might be right for
Hepatitis C ViralChronic Kidney Disease stage3
Kyushu University 80
Post-approval studies (Phase 4)Study completedNCT00077636
What this trial is testing

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,469
Not applicableStudy completedNCT00724464
What this trial is testing

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 332
Not applicableStudy completedNCT03144440
What this trial is testing

Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel

Who this might be right for
Hepatitis C
Carmel Medical Center 200
Post-approval studies (Phase 4)Ended earlyNCT00493805
What this trial is testing

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

Who this might be right for
Hepatitis C, ChronicInsulin Resistance
Merck Sharp & Dohme LLC 59
Post-approval studies (Phase 4)Study completedNCT00087646
What this trial is testing

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 948
Large-scale testing (Phase 3)WithdrawnNCT01296971
What this trial is testing

The Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00926120
What this trial is testing

The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC

Who this might be right for
Hepatitis C
Brooke Army Medical Center 10
Not applicableWithdrawnNCT01062659
What this trial is testing

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm
Large-scale testing (Phase 3)Study completedNCT00483938
What this trial is testing

The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 236
Not applicableUnknownNCT03340636
What this trial is testing

Residual Plasma Concentration of Sorafenib and Adverse Events in CHC

Who this might be right for
Advanced or Metastatic Hepatocellular Carcinoma
University Hospital, Caen 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation